
Science Behind MyStem
Comprehensive clinical data and scientific research supporting our regenerative medicine solutions.
Scientific Evidence
Data from laboratory analysis and clinical studies demonstrating the efficacy of MyStem and RegenX products.
RegenX Cytokine Response
Baseline vs RegenX (37°C, 3 hours incubation)
MyStem Cell Profile
CD Marker profile of isolated regenerative fraction
SVF Cell Count Comparison
Cells (×10⁶/ml) by extraction method
The Regenerative Process
Understanding the biological cascade triggered by autologous regenerative treatments.
Hemostasis
MinutesFibrin clot formation, platelet activation, vasoactive mediator release, growth factor secretion.
Inflammation
Hours-DaysChemotaxis, neutrophil and monocyte migration, macrophage phagocytosis, cytokine release.
Proliferation
Days-WeeksRe-epithelialization, angiogenesis, fibroplasia, keratinocyte migration and maturation.
Remodeling
Weeks-MonthsScar maturation, wound contraction, myofibroblast apoptosis, extracellular matrix remodeling.
Population We Can Help
Estimated percentages of population affected by conditions treatable with regenerative protocols.
OA (25+ years)
~500M globally
OA (65+ years)
~200M globally
Tendinopathy
~300M globally
Cartilage Injuries
~300M globally
Key Scientific References
Desando et al. "Intra-articular delivery of adipose derived stromal cells attenuates osteoarthritis progression." Arthritis Research & Therapy 2013.
Park et al. "Adipose-Derived Stem Cells and Their Secretory Factors as a promising Therapy for Skin Aging."
Park et al. "Hair growth stimulated by conditioned medium of adipose-derived stem cells is enhanced by hypoxia."
Tay et al. "Allogeneic and autologous MSCs have enhanced ability to regenerate tissue in focal cartilage defects."
Marquass et al. "Superior bonding of chondrogenically predifferentiated MSCs to native cartilage at 12 months in vivo."
Mishra et al. "PRP enhances stem cell proliferation and promotes chondrogenic differentiation - 10-fold increase in chondrogenic markers."
